» Articles » PMID: 23161904

Bone Oedema on MRI is Highly Associated with Low Bone Mineral Density in Patients with Early Inflammatory Back Pain: Results from the DESIR Cohort

Overview
Journal Ann Rheum Dis
Specialty Rheumatology
Date 2012 Nov 20
PMID 23161904
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To assess bone mineral density (BMD) at lumbar spine and hip in a large cohort of patients with early inflammatory back pain (IBP) suggestive of axial spondyloarthritis (SpA), and to assess systemic and bone inflammation (according to MRI) as risk factors of low BMD.

Patients And Methods: 332 (52.4% male) patients with IBP suggestive of axial SpA defined by Calin or Berlin criteria were recruited; they had lumbar spine and hip BMD and body composition measurements. Low BMD was defined by Z≤-2 (at least one site). Clinical, biological (erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP)) and imaging (x-rays, spine and sacroiliac joint MRI) parameters were compared in patients with and without low BMD (Z≤-2). Significant parameters in univariate analysis were tested in multivariate models.

Results: Patients (mean age 33.8 years) had a short duration of axial symptoms (mean 1.6 years); 71.4% fulfilled the Assessment of Spondyloarthritis International Society criteria for axial SpA and HLA-B27 was present in 62.1%. 43 (13.0%) had low BMD (88% male). Multivariate logistic regression showed that parameters significantly associated with low BMD (any site) were the presence of bone marrow oedema (inflammatory lesions) on MRI (OR 4.63, p=0.001), either ESR or CRP (OR 2.60, p=0.037) and male gender (OR 9.60, p=0.0004).

Conclusions: This study conducted in a large cohort of young adults with early IBP suggestive of SpA shows that 13.0% of patients have a low BMD and that the main risk factor associated with low BMD was inflammation on MRI.

Citing Articles

A comparison of comorbidities and their risk factors prevalence across rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis with focus on cardiovascular diseases: data from a single center real-world cohort.

Gula Z, Losinska K, Kuszmiersz P, Strach M, Nowakowski J, Biedron G Rheumatol Int. 2024; 44(12):2817-2828.

PMID: 39527279 PMC: 11618134. DOI: 10.1007/s00296-024-05740-z.


Osteoimmunology of Spondyloarthritis.

Fassio A, Atzeni F, Rossini M, DAmico V, Cantatore F, Chimenti M Int J Mol Sci. 2023; 24(19).

PMID: 37834372 PMC: 10573470. DOI: 10.3390/ijms241914924.


Prevalence of low trabecular bone score and its association with disease severity and activity in patients with axial spondyloarthritis.

Saisirivechakun P, Mahakkanukrauh A, Pongchaiyakul C, Boonya-Ussadorn T, Narongroeknawin P, Pakchotanon R Sci Rep. 2023; 13(1):16258.

PMID: 37758825 PMC: 10533482. DOI: 10.1038/s41598-023-43321-5.


Effect of insulin resistance on gonadotropin and bone mineral density in nondiabetic postmenopausal women.

Ye S, Shi L, Zhang Z Front Endocrinol (Lausanne). 2023; 14:1235102.

PMID: 37670878 PMC: 10475931. DOI: 10.3389/fendo.2023.1235102.


Inflammation, bone loss and 2-year bone formation at the same vertebra in axial spondyloarthritis: a multilevel MRI and low-dose CT analysis.

Marques M, Pereira da Silva N, van der Heijde D, Stal R, Baraliakos X, Braun J RMD Open. 2023; 9(1).

PMID: 36759008 PMC: 9923353. DOI: 10.1136/rmdopen-2022-002836.